Cancer stem cells

The Molecular Basis of Cancer

Volumn , Issue , 2008, Pages 141-154

  Buchstaller, Johanna ^a   Quintana, Elsa ^a   Morrison, Sean J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 58749097062     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-141603703-3.10010-X     Document Type: Chapter

References (106)

1. Fidler IJ, Hart IR Biological diversity in metastatic neoplasms: origins and implications. Science 1982, 217:998.
2. Heppner GH Tumor heterogeneity. Cancer Res 1984, 44:2259.
3. Nowell PC Mechanisms of tumor progression. Cancer Res 1986, 46:2203.
4. Nowell PC A minute chromosome in human granulocytic leukemia. Science 1960, 132:1497.
5. Fialkow PJ Clonal origin of human tumors. Biochim Biophys Acta 1976, 458:283.
6. Fearon ER, Hamilton SR, Vogelstein B Clonal analysis of human colorectal tumors. Science 1987, 238:193.
7. Kleinsmith LJ, Pierce GB Multipotentiality of single embryonal carcinoma cells. Cancer Res 1964, 24:1544.
8. Bonnet D, Dick JE Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Med 1997, 3:730.
9. Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukemia after transplantation into SCID mice. Nature 1994, 17:645.
10. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003, 100:3983.
11. Hemmati HD, Nakano I, Lazareff JA, et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A 2003, 100:15178.
12. Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003, 63:5821.
13. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105.
14. Pardal R, Clarke MF, Morrison SJ Applying the principles of stem-cell biology to cancer. Nature Cancer Rev 2003, 3:895.
15. Passegue E, Jamieson CH, Ailles LE, et al. Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?. Proc Natl Acad Sci U S A 2003, 100(Suppl 1):11842.
16. Jamieson CH, Ailles LE, Dylla SJ, et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 2004, 351:657.
17. Wang JC, Dick JE Cancer stem cells: lessons from leukemia. Trends Cell Biol 2005, 15:494.
18. Cozzio A, Passegue E, Ayton PM, et al. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev 2003, 17:3029.
19. Huntly BJ, Shigematsu H, Deguchi K, et al. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 2004, 6:587.
20. Hamburger AW, Salmon SE Primary bioassay of human tumor stem cells. Science 1977, 197:461.
21. Park CH, Bergsagel DE, McCulloch EA Mouse myeloma tumor stem cells: a primary cell culture assay. J Natl Cancer Inst 1971, 46:411.
22. Bruce WR, van der Gaag H A quantitative assay for the number of murine lymphoma cells capable of proliferation in vivo. Nature 1963, 199:79.
23. Wodinsky I, Swiniarski J, Kensler CJ Spleen colony studies of leukemia L1210. I. Growth kinetics of lymphocytic L1210 cells in vivo as determined by spleen colony assay. Cancer Chemother Rep 1967, 51:415.
24. Bergsagel DE, Valeriote FA Growth characteristics of a mouse plasma cell tumor. Cancer Res 1968, 28:2187.
25. Southam CM, Brunschwig A Quantitative studies of autotransplantation of human cancer. Cancer 1961, 14:971.
26. Fidler IJ, Kripke ML Metastasis results from preexisting variant cells within a malignant tumor. Science 1977, 197:893.
27. Illmensee K, Mintz B Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts. Proc Natl Acad Sci U S A 1976, 73:549.
28. Mintz B, Illmensee K Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci U S A 1975, 72:3585.
29. Brinster RL The effect of cells transferred into the mouse blastocyst on subsequent development. J Exp Med 1974, 140:1049.
30. Papaioannou VE, McBurney MW, Gardner RL, et al. Fate of teratocarcinoma cells injected into early mouse embryos. Nature 1975, 258:70.
31. Pierce GB, Dixon FJ, Verney EL Teratocarcinogenic and tissue-forming potentials of the cell types comprising neoplastic embryoid bodies. Lab Invest 1960, 9:583.
32. Horwich A, Shipley J, Huddart R Testicular germ-cell cancer. Lancet 2006, 367:754.
33. Gudjonsson T, Magnusson MK Stem cell biology and the cellular pathways of carcinogenesis. Apmis 2005, 113:922.
34. Sell S, Pierce GB Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab Invest 1994, 70:6.
35. Terstappen LWMM, Huang S, Safford M, et al. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38-progenitor cells. Blood 1991, 77:1218.
36. Huang S, Terstappen LW Lymphoid and myeloid differentiation of a single human CD34++, HLA-DR+, CD38- hematopoietic stem cell. Blood 1994, 83:1515.
37. Baum CM, Weissman IL, Tsukamoto AS, et al. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci U S A 1992, 89:2804.
38. Yahata T, Ando K, Sato T, et al. A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow. Blood 2003, 101:2905.
39. Morrison SJ, Weissman IL The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1994, 1:661.
40. Cheshier SH, Morrison SJ, Liao X, et al. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc Natl Acad Sci U S A 1999, 96:3120.
41. Terpstra W, Ploemacher RE, Prins A, et al. Fluorouracil selectively spares acute myeloid leukemia cells with long-term growth abilities in immunodeficient mice and in culture. Blood 1996, 88:1944.
42. Guan Y, Gerhard B, Hogge DE Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML). Blood 2003, 101:3142.
43. Blair A, Hogge DE, Ailles LE, et al. Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. Blood 1997, 89:3104.
44. Blair A, Sutherland HJ Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117). Exp Hematol 2000, 28:660.
45. Jordan CT, Upchurch D, Szilvassy SJ, et al. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia 2000, 14:1777.
46. Taipale J, Beachy PA The hedgehog and Wnt signaling pathways in cancer. Nature 2001, 411:349.
47. Pardal R, Molofsky AV, He S, et al. Stem cell self-renewal and cancer cell proliferation are regulated by common networks that balance the activation of proto-oncogenes and tumor suppressors. Cold Spring Harb Symp Quant Biol 2005, 70:177.
48. Jacobs JJL, Lohuizen Mv Polycomb repression: from cellular memory to cellular proliferation and cancer. Biochim Biophys Acta 2002, 1602:151.
49. Park I-K, Qian D, Kiel M, et al. Bmi-1 is required for the maintenance of adult self-renewing hematopoietic stem cells. Nature 2003, 423:302.
50. Molofsky AV, Pardal R, Iwashita T, et al. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 2003, 425:962.
51. Lessard J, Sauvageau G Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 2003, 423:255.
52. Molofsky AV, He S, Kruger GM, et al. Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev 2005, 19:1432.
53. Bruggeman SWM, Valk-Lingbeek ME, van der Stoop PPM, et al. Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi-1-deficient mice. Genes Dev 2005, 19:1438.
54. Cox CV, Evely RS, Oakhill A, et al. Characterization of acute lymphoblastic leukemia progenitor cells. Blood 2004, 104:2919.
55. Hanahan D, Weinberg RA The hallmarks of cancer. Cell 2000, 100:57.
56. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature 2004, 432:396.
57. Reynolds BA, Weiss S Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992, 255:1707.
58. Uchida N, Buck DW, He D, et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A 2000, 97:14720.
59. Eriksson PS, Perfilieva E, Bjork-Eriksson T, et al. Neurogenesis in the adult human hippocampus. Nature Med 1998, 4:1313.
60. Sanai N, Tramontin AD, Quinones-Hinojosa A, et al. Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature 2004, 427:740.
61. Fomchenko EI, Holland EC Stem cells and brain cancer. Exp Cell Res 2005, 306:323.
62. Donohue JP, Leviovitch I, Foster RS, et al. Integration of surgery and systemic therapy: results and principles of integration. Semin Urol Oncol 1998, 16:65.
63. Yilmaz OH, Valdez R, Theisen BK, et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 2006, 441:475.
64. Hope KJ, Jin L, Dick JE Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol 2004, 5:738.
65. Costello RT, Mallet F, Gaugler B, et al. Human acute myeloid leukemia CD34+/CD38? progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities. Cancer Res 2000, 60:4403.
66. Guzman ML, Neering SJ, Upchurch D, et al. Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood 2001, 98:2301.
67. Druker BJ, Tamura S, Buchdunger E, et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 1996, 2:561.
68. Druker BJ, Talpaz M, Resta DJ, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001, 344:1031.
69. Druker BJ, Sawyers CL, Kantarjian H, et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 2001, 344:1038.
70. Graham SM, Jorgensen HG, Allan E, et al. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood 2002, 99:319.
71. Bhatia R, Holtz M, Niu N, et al. Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment. Blood 2003, 101:4701.
72. le Coutre P, Tassi E, Varella-Garcia M, et al. Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification. Blood 2000, 95:1758.
73. Goldman J, Gordon M Why do chronic myelogenous leukemia stem cells survive allogeneic stem cell transplantation or imatinib: does it really matter?. Leuk Lymph 2006, 47:1.
74. Grabher C, von Boehmer H, Look AT Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev Cancer 2006, 6:347.
75. Molofsky AV, Pardal R, Morrison SJ Diverse mechanisms regulate stem cell self-renewal. Curr Opin Cell Biol 2004, 16:700.
76. Wechsler-Reya R, Scott MP The developmental biology of brain tumors. Annu Rev Neurosci 2001, 24:385.
77. Leung C, Lingbeek M, Shakhova O, et al. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 2004, 428:337.
78. Zencak D, Lingbeek M, Kostic C, et al. Bmi1 loss produces an increase in astroglial cells and a decrease in neural stem cell population and proliferation. J Neurosci 2005, 25:5774.
79. Di Cristofano A, Pandolfi PP The multiple roles of PTEN in tumor suppression. Cell 2000, 100:387.
80. Aggerholm A, Gronbaek K, Guldberg P, et al. Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders. Eur J Haematol 2000, 65:109.
81. Cheong JW, Eom JI, Maeng HY, et al. Phosphatase and tensin homologue phosphorylation in the C-terminal regulatory domain is frequently observed in acute myeloid leukaemia and associated with poor clinical outcome. Br J Haematol 2003, 122:454.
82. Dahia PL, Aguiar RC, Alberta J, et al. PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanisms in haematological malignancies. Hum Mol Genet 1999, 8:185.
83. Roman-Gomez J, Jimenez-Velasco A, Castillejo JA, et al. Promoter hypermethylation of cancer-related genes. A strong independent prognostic factor in acute lymphoblastic leukemia. Blood 2004, 104:2492.
84. Teachey DT, Obzut DA, Cooperman J, et al. The mTOR inhibitor CCI-779 induces apoptosis and inhibits growth in preclinical models of primary adult human ALL. Blood 2006, 107:1149.
85. Avellino R, Romano S, Parasole R, et al. Rapamycin stimulates apoptosis of childhood acute lymphoblastic leukemia cells. Blood 2005, 106:1400.
86. Recher C, Beyne-Rauzy O, Demur C, et al. Antileukemic activity of rapamycin in acute myeloid leukemia. Blood 2005, 105:2527.
87. Margolin K, Longmate J, Baratta T, et al. CCI-779 in metastatic melanoma: a phase II trial of the California Cancer Consortium. Cancer 2005, 104:1045.
88. Chang SM, Wen P, Cloughesy T, et al. Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme. Invest New Drugs 2005, 23:357.
89. Guzman ML, Rossi RM, Karnischky L, et al. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood 2005, 105:4163.
90. Guzman ML, Swiderski CF, Howard DS, et al. Preferential induction of apoptosis for primary human leukemic stem cells. Proc Natl Acad Sci U S A 2002, 99:16220.
91. Pierce GB, Speers WC Tumors as caricatures of the process of tissue renewal: prospects for therapy by directing differentiation. Cancer Res 1988, 48:1996.
92. Huang ME, Ye YC, Chen SR, et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988, 72:567.
93. Degos L, Dombret H, Chomienne C, et al. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood 1995, 85:2643.
94. Warrell RP, Frankel SR, Miller WH, et al. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 1991, 324:1385.
95. Jain M, Arvanitis C, Chu K, et al. Sustained loss of a neoplastic phenotype by brief inactivation of MYC. Science 2002, 297:102.
96. Salsbury AJ The significance of the circulating cancer cell. Cancer Treat Rev 1975, 2:55.
97. Kummermehr J, Trott K-R Stem Cells 1997, 363. Academic Press, New York. C.S. In: Potten (Ed.).
98. Doetsch F, Caille I, Lim DA, et al. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 1999, 97:703.
99. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111.
100. O'Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiatng tumour growth in immunodeficient mice. Nature 2007, 445:106.
101. Castor A, Nilsson L, Astrand-Grundstrom I, et al. Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia. Nat Med 2005, 11:630.
102. Yilmaz OH, Valdez R, Theisen BK, et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 2006, 441:475.
103. Kelly PN, Dakic A, Adams JM, et al. Tumor growth need not be driven by rare cancer stem cells. Science 2007, 317:337.
104. Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756.
105. Hermann PC, Huber SL, Herrier T, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007, 1:313.
106. Piccirillo SG, Reynolds BA, Zanetti N, et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiatig cells. Nature 2006, 444:761.